AAAlina Alsatou

Alina Alsatou

*This is an algorithmically generated author record based on publicly available information.

Alina Alsatou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Venous thromboembolism in pregnancy: therapeutic options

    by Hristiana Capros, Iurie Dondiuc, Alina Alsatou, Mihail Surguci, Luminita Mihalceanu, Mihaela Burac

    Introduction. Venous thromboembolism is a rare but significant cause of maternal morbidity and mortality during pregnancy and postpartum, affecting 1 in 1,000-2,000 pregnancies. Despite advancements in the treatment of venous thromboembolism in the general population, its management during pregnancy remains a challenge due to therapeutic limitations and the risks associated with anticoagulants for both the mother and the fetus. Prevention and treatment predominantly rely on the use of unfractionated heparin or low-molecular-weight heparin, which, while effective, are associated with maternal and fetal risks such as thrombocytopenia, osteoporosis, and neonatal bleeding. Methods. The study included original articles from specialized journals such as PubMed, Cochrane Library, and Google Scholar, focusing on venous thromboembolism, deep vein thrombosis, and pulmonary embolism during pregnancy. Articles on superficial venous thrombosis, arterial thrombosis, and other uncommon locations were excluded. The search strategy used controlled terms and relevant keywords. Results. Venous thromboembolism is the leading cause of maternal mortality in developed countries, with a postpartum risk of pulmonary embolism up to 35 times higher than during the antepartum period. Pregnancy-specific hypercoagulability is influenced by physiological factors such as increased levels of fibrinogen and coagulation factors. Hemostatic changes, mechanical compression of pelvic veins, and venous stasis contribute to the predisposition for venous thromboembolism. Anticoagulant treatments such as low-molecular-weight heparin and unfractionated heparin are most commonly used, involving distinct therapeutic phases: initial, primary, and extended, each with specific objectives in preventing venous thromboembolism recurrence. Conclusions. Managing venous thromboembolism during pregnancy requires personalized approaches that balance the risks and benefits of anticoagulation. Improving treatment strategies depends on further research to evaluate the safety and efficacy of new anticoagulants, particularly during pregnancy and postpartum.

  • Impact of umbilical cord pathology on perinatal outcomes: risk factors and clinical implications

    by Iurie Dondiuc, Alina Alsatou, Hristiana Capros

    Introduction. Umbilical cord pathology can contribute to neonatal asphyxia, stillbirth, and postnatal death in numerous cases. However, the diagnosis of umbilical cord pathology remains imperfect, and its impact on pregnancy course and outcome is often underestimated. Therefore, prenatal diagnosis of umbilical cord pathology is becoming increasingly important in preventing intra- and postnatal morbidity and mortality. Early detection of these abnormalities enables the development of necessary strategies for optimal pregnancy and delivery management. Material and methods. The study included 190 patients divided into 2 groups: L1 – 95 patients with UC abnormalities, and L0 – 95 with a normal UC. A p-value of less than 0.05 was regarded as statistically significant. Results. The development of umbilical cord pathology was frequently observed in pregnant women exposed to harmful workplace factors (psychological and emotional stress, p=0.01), harmful habits (smoking, p=0.04), and primiparas (p=0.005) with complicated gynecological and somatic histories, as well as those with a history of UC pathology in previous pregnancies (p<0.0001). Pregnancy and labor progression in patients with cord pathology showed a high rate of complications compared to control group, including urinary tract disorders (p=0.02), preterm labor at 27-28 weeks (p=0.01), polyhydramnios, which was ten times more frequent (p=0.002), and fetal growth restriction (p=0.02). In the study group, a prolonged second stage of labor was observed (p=0.01), along with acute fetal hypoxia, which required urgent pregnancy termination (p=0.01) through vacuum extraction (p=0.0009) or C-section (p=0.04). Conclusions. The analysis of the anamnestic and clinical peculiarities of the perinatal period in patients with UC pathology, compared to pregnant women without this pathology, confirmed that this commonly encountered obstetric condition represents a considerable risk factor for perinatal complications.